Celldex Therapeutics, Inc. ( CLDX) - Key Metrics
CLDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0.02 | -$0.71 | -$0.49 | -$0.50 |
| 2024Q3 | $0.05 | -$0.64 | -$0.83 | -$0.83 |
| 2024Q2 | $0.04 | -$0.54 | -$0.44 | -$0.45 |
| 2024Q1 | $0 | -$0.56 | -$0.69 | -$0.70 |
| 2023Q4 | $0.08 | -$0.83 | -$0.63 | -$0.64 |
CLDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -8.90 |
| 2024Q3 | ? | -13.37 |
| 2024Q2 | ? | -17.95 |
| 2024Q1 | ? | -18.68 |
| 2023Q4 | ? | -11.91 |
CLDX
Price: $21.17
52 week price:
Earnings Per Share: -2.70 USD
P/E Ratio: -7.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 1.3 billion